TI-201 has been used mainly as a myocardial perfusion agent. Its use as a tumor agent was first described in 1976, and many types of malignancies have been detected with TI-201. However, scintigraphic detection of esophageal cancer by TI-201 has rarely been reported.
- Esophageal Cancer
- TI-201 Chest SPECT
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Radiological and Ultrasound Technology